Skip to Content

Open House Slated for TPSR

May 24, 2012 | Dagny Stuart

Mary Zutter, M.D.

The Translational Pathology Shared Resource (TPSR) has opened an expanded laboratory on the first floor of Medical Center North, room S-1310.

To celebrate the grand opening of the newly renovated space, TPSR is hosting an open house on Wednesday, May 30, from 1-3 p.m.
Vanderbilt faculty and staff are invited to tour the new space, meet the staff and discover how the enterprise can help advance research.

The TPSR is Vanderbilt’s “pathology powerhouse” and is designed to translate basic science discoveries into new prevention and treatment options for patients. The operation is a collaboration of human and veterinary pathology providing comprehensive translational pathology support for investigators working with human tissue-based assays or animal models.

“Our goal is to help investigators generate novel information from tissue-based assays,” said Mary Zutter, M.D., assistant vice chancellor for Integrative Diagnostics and scientific director of the new resource.

The consolidated service is centrally located between the clinical services and research laboratories and supports more than 150 VUMC investigators engaged in basic and clinical research. The TPSR is open Monday through Friday, 7 a.m. to 4:30 p.m.

TPSR consists of three integrated divisions; Research Histology, Comparative Pathology and Tissue Acquisition.

• The Research Histology Division provides full service histology, including immunohistochemistry on all research tissue specimens. The operation offers a full menu of immunoassays with a library of more than 200 antibodies developed for specific projects. The lab has two laser capture microscopes.

Kelli Boyd, DVM., Ph.D.

• The Comparative Pathology Division provides clinical testing and anatomic pathology services for animal models, including comprehensive phenotyping of genetically-engineered mice.

• The Tissue Acquisition Division provides collection and distribution of tissue samples suitable for molecular, biochemical or tissue analysis. The operation has expanded its collection of tissues to develop a hematologic malignancy tumor bank and to provide increased accessibility to de-identified solid tumors.

“This newly expanded resource will provide our investigators with the expertise and state-of-the-art equipment needed to support and advance their important research,” said Kelli Boyd, DVM., Ph.D., associate professor of Pathology, Microbiology and Immunology and director of the Comparative Pathology and Research Histology Services.

The renovation was financed through institutional support from Vanderbilt University Medical Center, Vanderbilt-Ingram Cancer Center, the Division of Animal Care and the Office of Research. Funding was also provided through a $1.3 million American Recovery and Reinvestment Act supplement to VICC’s Cancer Center Support Grant from the National Cancer Institute, (P30 CA068485). The NCI is a branch of the National Institutes of Health.